Cargando…

m(6)A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication

The epitranscriptomic modification N(6)-methyladenosine (m(6)A) is a ubiquitous feature of the mammalian transcriptome. It modulates mRNA fate and dynamics to exert regulatory control over numerous cellular processes and disease pathways, including viral infection. Kaposi’s sarcoma-associated herpes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manners, Oliver, Baquero-Perez, Belinda, Mottram, Timothy J., Yonchev, Ivaylo D., Trevelyan, Christopher J., Harper, Katherine L., Menezes, Sarah, Patterson, Molly R., Macdonald, Andrew, Wilson, Stuart A., Aspden, Julie L., Whitehouse, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303434/ https://www.ncbi.nlm.nih.gov/pubmed/37376680 http://dx.doi.org/10.3390/v15061381

Ejemplares similares

Dysregulation of the miR‐30c/DLL4 axis by circHIPK3 is essential for KSHV lytic replication
por: Harper, Katherine L, et al.
Publicado: (2022)

Contribution of the KSHV and EBV lytic cycles to tumourigenesis
por: Manners, Oliver, et al.
Publicado: (2018)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

The Tudor SND1 protein is an m(6)A RNA reader essential for replication of Kaposi’s sarcoma-associated herpesvirus
por: Baquero-Perez, Belinda, et al.
Publicado: (2019)

NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target
por: Hughes, David J., et al.
Publicado: (2015)

m(6)A: Widespread regulatory control in virus replication()
por: Manners, Oliver, et al.
Publicado: (2019)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

Activation of DNA Damage Response Pathways during Lytic Replication of KSHV
por: Hollingworth, Robert, et al.
Publicado: (2015)

Interactions between KSHV ORF57 and the novel human TREX proteins, CHTOP and CIP29
por: Schumann, Sophie, et al.
Publicado: (2016)

Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
por: Park, Mi-Kyung, et al.
Publicado: (2019)

Kaposi’s sarcoma-associated herpesvirus induces specialised ribosomes to efficiently translate viral lytic mRNAs
por: Murphy, James C., et al.
Publicado: (2023)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

The SUMO E3 ligase activity of ORF45 determines KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2022)

Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition
por: Li, Xiaojuan, et al.
Publicado: (2023)

Epigenetic Analysis of KSHV Latent and Lytic Genomes
por: Toth, Zsolt, et al.
Publicado: (2010)

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication
por: Johnston, Benjamin P., et al.
Publicado: (2019)

NDRG1 facilitates lytic replication of Kaposi’s sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase
por: Dong, Lianghui, et al.
Publicado: (2021)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

SUMO and KSHV Replication
por: Chang, Pei-Ching, et al.
Publicado: (2014)

The activation of KSHV lytic cycle blocks autophagy in PEL cells
por: Granato, Marisa, et al.
Publicado: (2015)

The landscape of transcription initiation across latent and lytic KSHV genomes
por: Ye, Xiang, et al.
Publicado: (2019)

Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication
por: Avey, Denis, et al.
Publicado: (2015)

K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: A Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis
por: Zhao, Jinshun, et al.
Publicado: (2007)

KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression
por: Kaul, Rajeev, et al.
Publicado: (2019)

iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release
por: Dollery, Stephen J., et al.
Publicado: (2021)

Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system
por: Li, Dajiang, et al.
Publicado: (2019)

KSHV Reactivation and Novel Implications of Protein Isomerization on Lytic Switch Control
por: Guito, Jonathan, et al.
Publicado: (2015)

Efficient lytic induction of kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines
por: Kang, Hyunju, et al.
Publicado: (2014)

KSHV Genome Replication and Maintenance
por: Purushothaman, Pravinkumar, et al.
Publicado: (2016)

KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation
por: Singh, Rajnish Kumar, et al.
Publicado: (2019)

Resveratrol Inhibits KSHV Reactivation by Lowering the Levels of Cellular EGR-1
por: Dyson, Ossie F., et al.
Publicado: (2012)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

Hsp70 Isoforms Are Essential for the Formation of Kaposi’s Sarcoma-Associated Herpesvirus Replication and Transcription Compartments
por: Baquero-Pérez, Belinda, et al.
Publicado: (2015)

C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
por: O’Farrell, Courtney, et al.
Publicado: (2010)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV
por: Naik, Nenavath Gopal, et al.
Publicado: (2020)

The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target
por: Abere, Bizunesh, et al.
Publicado: (2017)

KSHV PAN RNA Associates with Demethylases UTX and JMJD3 to Activate Lytic Replication through a Physical Interaction with the Virus Genome
por: Rossetto, Cyprian C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kg4g51c79pa107lgo4dsp9pqv5